Published in Physiology (Bethesda) on April 01, 2011
Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. J Clin Invest (2011) 1.48
Proteasome functional insufficiency in cardiac pathogenesis. Am J Physiol Heart Circ Physiol (2011) 1.11
p62 Stages an interplay between the ubiquitin-proteasome system and autophagy in the heart of defense against proteotoxic stress. Trends Cardiovasc Med (2011) 0.98
Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human. Mol Cell Proteomics (2013) 0.91
Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics. Am J Physiol Heart Circ Physiol (2012) 0.87
Clarifying the cardiac proteasome paradox: protein quality control. Circ Res (2012) 0.81
Ubiquitin and ubiquitin-like proteins in cardiac disease and protection. Curr Drug Targets (2015) 0.75
The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol (2007) 10.24
Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles. J Proteome Res (2009) 3.77
A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science (2007) 3.73
Role of the mitochondrial permeability transition in myocardial disease. Circ Res (2003) 3.26
The crystal structure of mouse VDAC1 at 2.3 A resolution reveals mechanistic insights into metabolite gating. Proc Natl Acad Sci U S A (2008) 2.82
BioJS: an open source JavaScript framework for biological data visualization. Bioinformatics (2013) 2.53
Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res (2003) 2.52
Mapping the murine cardiac 26S proteasome complexes. Circ Res (2006) 2.17
Regulation of murine cardiac 20S proteasomes: role of associating partners. Circ Res (2006) 1.81
Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci (2005) 1.75
Divergent mitochondrial biogenesis responses in human cardiomyopathy. Circulation (2013) 1.69
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation (2011) 1.66
Crystal packing analysis of murine VDAC1 crystals in a lipidic environment reveals novel insights on oligomerization and orientation. Channels (Austin) (2009) 1.57
Metabolic labeling reveals proteome dynamics of mouse mitochondria. Mol Cell Proteomics (2012) 1.53
Systematic characterization of the murine mitochondrial proteome using functionally validated cardiac mitochondria. Proteomics (2008) 1.51
Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. Am J Physiol Heart Circ Physiol (2004) 1.51
Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS. Mol Cell Proteomics (2002) 1.44
Cyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injury. J Mol Cell Cardiol (2008) 1.44
Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol Cell Proteomics (2010) 1.41
Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities. Mol Cell Proteomics (2007) 1.41
Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Invest (2009) 1.36
Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy. Circ Res (2010) 1.34
Loss of ABCG1 results in chronic pulmonary inflammation. J Immunol (2008) 1.32
Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. J Cell Sci (2004) 1.31
Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues. Mol Cell Proteomics (2008) 1.29
Post-translational modifications of integral membrane proteins resolved by top-down Fourier transform mass spectrometry with collisionally activated dissociation. Mol Cell Proteomics (2010) 1.28
Reactive oxygen species production in energized cardiac mitochondria during hypoxia/reoxygenation: modulation by nitric oxide. Circ Res (2008) 1.24
Revealing the dynamics of the 20 S proteasome phosphoproteome: a combined CID and electron transfer dissociation approach. Mol Cell Proteomics (2008) 1.19
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol (2006) 1.19
Altered proteome biology of cardiac mitochondria under stress conditions. J Proteome Res (2008) 1.16
Integration of cardiac proteome biology and medicine by a specialized knowledgebase. Circ Res (2013) 1.15
ABCC6 localizes to the mitochondria-associated membrane. Circ Res (2012) 1.14
Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J Mol Cell Cardiol (2013) 1.14
Proteomic and metabolomic analysis of cardioprotection: Interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts. J Mol Cell Cardiol (2008) 1.13
Functional proteomic analysis of a three-tier PKCepsilon-Akt-eNOS signaling module in cardiac protection. Am J Physiol Heart Circ Physiol (2004) 1.11
PKCepsilon activation augments cardiac mitochondrial respiratory post-anoxic reserve--a putative mechanism in PKCepsilon cardioprotection. J Mol Cell Cardiol (2005) 1.08
Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte. Circ Res (2010) 1.08
Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics (2005) 1.08
Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights. Mol Cell Proteomics (2006) 1.06
Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemic H(+) production. J Mol Cell Cardiol (2002) 1.06
Substrate- and isoform-specific proteome stability in normal and stressed cardiac mitochondria. Circ Res (2012) 1.02
Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems. J Neurosci Res (2006) 1.02
Mitochondrial permeability transition in cardiac cell injury and death. Cardiovasc Drugs Ther (2006) 1.01
Scaffold proteins and assembly of multiprotein signaling complexes. J Mol Cell Cardiol (2004) 1.00
Protein kinetic signatures of the remodeling heart following isoproterenol stimulation. J Clin Invest (2014) 0.99
Exploring proteasome complexes by proteomic approaches. Proteomics (2007) 0.98
Protein degradation by the 26S proteasome system in the normal and stressed myocardium. Antioxid Redox Signal (2006) 0.98
An MRM-based workflow for quantifying cardiac mitochondrial protein phosphorylation in murine and human tissue. J Proteomics (2012) 0.96
Specialized compartments of cardiac nuclei exhibit distinct proteomic anatomy. Mol Cell Proteomics (2010) 0.95
Characterization, design, and function of the mitochondrial proteome: from organs to organisms. J Proteome Res (2013) 0.94
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles). Mol Cell Proteomics (2011) 0.94
Data-Driven Approach To Determine Popular Proteins for Targeted Proteomics Translation of Six Organ Systems. J Proteome Res (2016) 0.93
Understanding proteasome assembly and regulation: importance to cardiovascular medicine. Trends Cardiovasc Med (2008) 0.92
Past and present course of cardioprotection against ischemia-reperfusion injury. J Appl Physiol (1985) (2007) 0.92
Molecular conformation dictates signaling module formation: example of PKCepsilon and Src tyrosine kinase. Am J Physiol Heart Circ Physiol (2002) 0.91
Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human. Mol Cell Proteomics (2013) 0.91
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles). J Proteome Res (2011) 0.91
Mitochondrial Function, Biology, and Role in Disease: A Scientific Statement From the American Heart Association. Circ Res (2016) 0.91
PPM1l encodes an inositol requiring-protein 1 (IRE1) specific phosphatase that regulates the functional outcome of the ER stress response. Mol Metab (2013) 0.90
Two-dimensional electrophoresis-based characterization of post-translational modifications of mammalian 20S proteasome complexes. Proteomics (2008) 0.89
Site-specific quantitative analysis of cardiac mitochondrial protein phosphorylation. J Proteomics (2012) 0.89
Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Proteomics approaches to the systems biology of cardiovascular diseases. J Lipid Res (2006) 0.87
Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles). Proteomics (2011) 0.87
Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics. Am J Physiol Heart Circ Physiol (2012) 0.87
Beta-adrenergic receptor blockade modulates Bcl-X(S) expression and reduces apoptosis in failing myocardium. J Mol Cell Cardiol (2003) 0.87
Characterization of human plasma proteome dynamics using deuterium oxide. Proteomics Clin Appl (2014) 0.86
Cardioprotection involves activation of NF-kappa B via PKC-dependent tyrosine and serine phosphorylation of I kappa B-alpha. Am J Physiol Heart Circ Physiol (2003) 0.85
The murine cardiac 26S proteasome: an organelle awaiting exploration. Ann N Y Acad Sci (2005) 0.84
Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015. J Am Heart Assoc (2015) 0.84
Bmx, a member of the Tec family of nonreceptor tyrosine kinases, is a novel participant in pharmacological cardioprotection. Am J Physiol Heart Circ Physiol (2004) 0.83
New insights into the functional significance of the acidic region of the unique N-terminal extension of cardiac troponin I. Biochim Biophys Acta (2012) 0.83
Prioritizing Proteomics Assay Development for Clinical Translation. J Am Coll Cardiol (2015) 0.82
Multiprotein signaling complexes and regulation of cardiac phenotype. J Mol Cell Cardiol (2003) 0.82
Protein tyrosine kinase signaling is necessary for NO donor-induced late preconditioning against myocardial stunning. Am J Physiol Heart Circ Physiol (2002) 0.81
Proteome dynamics and proteome function of cardiac 19S proteasomes. Mol Cell Proteomics (2011) 0.81
A novel spectral library workflow to enhance protein identifications. J Proteomics (2013) 0.80
HUPO 2011: The new Cardiovascular Initiative - integrating proteomics and cardiovascular biology in health and disease. Proteomics (2012) 0.80
Response to Pomozi et al's research commentary. Circ Res (2013) 0.79
Embryonic stem cells attenuate viral myocarditis in murine model. Cell Transplant (2002) 0.79
Molecular- and organelle-based predictive paradigm underlying recovery by left ventricular assist device support. Circ Heart Fail (2014) 0.78
Perspectives on: SGP symposium on mitochondrial physiology and medicine: mitochondrial proteome design: from molecular identity to pathophysiological regulation. J Gen Physiol (2012) 0.78